Blog

Reframing Pharmacogenomics in Modern Oncology: From Reactive Testing to Longitudinal Care

By April 16, 2026May 7th, 2026No Comments

We’re proud to share a recent article by Houda Hachad, Vice President of Clinical Operations at Aranscia®, exploring the expanding role of pharmacogenomics in oncology care. “Reframing Pharmacogenomics in Modern Oncology: From Reactive Testing to Longitudinal Care” highlights how longitudinal PGx strategies can support more informed prescribing decisions and personalized treatment approaches across the continuum of care.

Read the full article: https://www.healthitanswers.net/reframing-pharmacogenomics-in-modern-oncology-from-reactive-testing-to-longitudinal-care/